Dipraglurant pharmacokinetics and tolerability in older volunteers.

Trial Profile

Dipraglurant pharmacokinetics and tolerability in older volunteers.

Phase of Trial: Phase I

Latest Information Update: 28 Jan 2009

At a glance

  • Drugs Dipraglurant (Primary)
  • Indications Drug-induced dyskinesia; Parkinson's disease
  • Focus Adverse reactions; Pharmacokinetics
  • Sponsors Addex Therapeutics
  • Most Recent Events

    • 28 Jan 2009 Status changed from recruiting to completed, as reported in an Addex Pharmaceuticals media release.
    • 28 Oct 2008 New trial record.
    • 15 Oct 2008 According to Addex Pharmaceuticals, topline results are expected before the end of 2008.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top